Kadence Bio
Phase 1Kadence Bio is a clinical stage therapeutics company whose mission is to develop innovative therapeutics that address critical unmet needs in sexual and mental health. We are developing the FDA-approved treatment for premature ejaculation.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Funding information not available
About
Kadence Bio is a clinical stage therapeutics company whose mission is to develop innovative therapeutics that address critical unmet needs in sexual and mental health. We are developing the FDA-approved treatment for premature ejaculation.
Small Molecules